KDM5C and neoplasm: In this study, we observed that KDM5C altered tumors had markedly higher TMB and were associated with anti-antitumor immune signatures, indicating that KDM5C altered tumors would possess the enhanced tumor immunogenicity and relatively immunosupportive microenvironment, supporting its predictive value to ICI treatment.